Edesa Biotech (EDSA) Stock
Publicly traded company. Here's the price, business snapshot, and what's worth knowing about Edesa Biotech in October 2026.
Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company developing ways to treat inflammatory and immune-related diseases. The Company’s clinical pipeline is focused on two therapeutic areas: medical dermatology and respiratory. In medical dermatology, the Company is developing EB06, an anti-CXCL10 monoclonal antibody candidate, as a therapy for vitiligo, a common autoimmune disorder that causes skin to lose its color in patches. Its medical dermatology assets also include EB01 (1.0% daniluromer cream), a Phase III-ready asset developed for use as a potential therapy for moderate-to-severe chronic allergic contact dermatitis (ACD), a common occupational skin condition. The Company’s advanced respiratory drug candidate is EB05 (paridiprubart), which is being evaluated in a United States government-funded platform study as a treatment for acute respiratory distress syndrome.
Edesa Biotech (EDSA) Stock Forecast
Analyst price target, next 12 months
$15.33
+297.2% vs today's $3.86
Price range over the last 12 months
Close to its 12-month low
Analysts covering Edesa Biotech have a consensus 12-month target of $15.33, above the current price of $3.86.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 17 Sep 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying EDESA's stock with a target price of $15.33, indicating strong growth potential.
Financial Health
EDESA Biotech is showing strong cash flow and a solid book value, indicating favorable financial health.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
